CCLD Stock Analysis: Buy, Sell, or Hold?
CCLD - CareCloud, Inc. Common Stock
$2.21
0.09 (4.25%)
▲
5d:
-1.34%
30d:
-6.36%
90d:
-38.78%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When CCLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CCLD appears deeply undervalued. Market expects -13.8% annual earnings decline despite 5739% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: CCLD appears deeply undervalued. Market expects -13.8% annual earnings decline despite 5739% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.23
Based on -8.0% avg growth
INTRINSIC VALUE TODAY
$1.39
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CCLD is currently trading at $2.21, which is considered slightly low relative to its 30-day fair value range of $2.20 to $2.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.5) compared to its historical average (11.8). Remarkably, the market is currently pricing in an annual earnings decline of 13.8% over the next few years. This pessimistic expectation contrasts with the company's recent 5739.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.11, while resistance sits at $2.44. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.12 (+177.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.11, while resistance sits at $2.44. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.12 (+177.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.20 -
$2.39
Company Quality Score
54/100
(HOLD)
Options IV Signal
34th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
81.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 34th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 177.1% below Wall St target ($6.12)
Trading Range Analysis
30-Day Trading Range
$2.20 -
$2.39
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.24
(11.1%)
Support & Resistance Levels
Support Level
$2.11
Resistance Level
$2.45
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.53
Wall Street Target
$6.13
(+177.1%)
Revenue Growth (YoY)
13.2%
Earnings Growth (YoY)
5739.0%
Profit Margin
7.9%
Valuation Discount vs History
-13.8% cheaper
PE vs Historical
7.5 vs 11.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.8%
(market-implied from PE analysis)
1-Year Target
$1.99
(-10%)
2-Year Target
$1.79
(-19%)
3-Year Target
$1.61
(-27%)
3-Yr Target (if PE normalizes)
(PE: 8→12)
$2.52
(+14%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -20.0%)
$4.66
(+111%)
Base:
(SPY PE: 7.5, Growth: -20.0%)
$1.61
(-27%)
Bear:
(PE: 6.4, Growth: -20.0%)
$1.37
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 16.31 | Current EPS (TTM): $0.13
Bull Case
$4.66
(+111%)
Analyst growth 100.0%, PE expands to 17.9
Base Case
$4.24
(+92%)
Market implied 100.0%, PE stable at 16.3
Bear Case
$1.44
(-35%)
Severe decline -20.0%, PE contracts to 13.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.5 to 11.8
Stabilization Target:
$3.46
(+56.6%)
PE Expansion Potential:
+56.6%
Share & Embed Analysis
Last updated: June 24, 2026 9:06 AM ET
Data refreshes hourly during market hours. Next update: 10:06 AM
Data refreshes hourly during market hours. Next update: 10:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 51 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 53 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 56 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 57 HOLD |
